Frank Rimerman Advisors LLC Sells 1,686 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• Frank Rimerman Advisors LLC reduced its position in UnitedHealth Group by 10.0%, selling 1,686 shares during the 1st quarter, leaving them with a total of 15,177 shares valued at approximately $7.9 million.
• Several institutional investors have significantly increased their holdings in UnitedHealth Group, including GAMMA Investing LLC, which grew by 56,142.1% to own over 8 million shares valued at $4.34 billion.
• UnitedHealth Group's recent quarterly earnings reported an EPS of $4.08, missing estimates, while the company also announced a dividend increase to $2.21 per share, marking a 5.24% rise from the previous quarter.

Frank Rimerman Advisors LLC reduced its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 10.0% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 15,177 shares of the healthcare conglomerate's stock after selling 1,686 shares during the quarter. UnitedHealth Group comprises about 0.6% of Frank Rimerman Advisors LLC's portfolio, making the stock its 22nd largest position. Frank Rimerman Advisors LLC's holdings in UnitedHealth Group were worth $7,949,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in UNH. GAMMA Investing LLC grew its holdings in shares of UnitedHealth Group by 56,142.1% during the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after purchasing an additional 8,280,404 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of UnitedHealth Group by 6.6% during the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after purchasing an additional 5,583,343 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of UnitedHealth Group by 36.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock valued at $4,346,712,000 after purchasing an additional 2,301,010 shares during the last quarter. Northern Trust Corp grew its holdings in UnitedHealth Group by 12.5% during the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock worth $4,807,527,000 after acquiring an additional 1,058,488 shares during the last quarter. Finally, National Bank of Canada FI grew its holdings in UnitedHealth Group by 137.8% during the 1st quarter. National Bank of Canada FI now owns 1,641,177 shares of the healthcare conglomerate's stock worth $859,518,000 after acquiring an additional 950,928 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, CFO John F. Rex acquired 17,175 shares of the firm's stock in a transaction that occurred on Friday, May 16th. The stock was acquired at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the acquisition, the chief financial officer owned 203,796 shares of the company's stock, valued at approximately $59,329,091.52. This represents a 9.20% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Stephen J. Hemsley acquired 86,700 shares of the firm's stock in a transaction that occurred on Friday, May 16th. The shares were bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the acquisition, the chief executive officer directly owned 679,493 shares of the company's stock, valued at $196,081,295.01. The trade was a 14.63% increase in their position. The disclosure for this purchase can be found here. Insiders have bought a total of 109,408 shares of company stock valued at $31,607,768 over the last 90 days. 0.28% of the stock is currently owned by company insiders.

UnitedHealth Group Stock Performance

UNH opened at $250.74 on Friday. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The company's fifty day moving average price is $291.78 and its two-hundred day moving average price is $406.82. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The company has a market cap of $227.46 billion, a price-to-earnings ratio of 10.86, a PEG ratio of 1.58 and a beta of 0.43.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business's revenue for the quarter was up 12.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.80 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a $2.21 dividend. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a dividend yield of 3.5%. The ex-dividend date was Monday, June 16th. UnitedHealth Group's dividend payout ratio is currently 38.30%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the stock. Truist Financial reduced their target price on shares of UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating on the stock in a report on Wednesday, July 16th. UBS Group reissued a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Baird R W cut shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Raymond James Financial cut shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research report on Wednesday, May 14th. Finally, KeyCorp decreased their price objective on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Three investment analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $366.52.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.